Project list item
A revolutionary shape memory alloy-based disposable device for bladder cancer removal

European Commission

USD 55,967
2019 - 2019
Project list item
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

National Cancer Institute to HIKMAT AL-AHMADIE

USD 821,670
2019 - 2024
Project list item
Cell-biological mechanisms of the urinary bladder multifocal tumor formation (postdoctoral research project)

Slovenian Research Agency to Jerman Urška Dragin

 
2019 - 2021
Project list item
Clonal evolution and molecular stratification of urothelial carcinoma in situ of the urinary bladder

German Research Foundation to Stefan Garczyk, Nadine Gaisa

 
2019 -
Project list item
Mammalian SWI/SNF complexes in urothelial bladder cancer: analysis of the tumorbiological role of ARID1A and identification of potential ARID1A-deficiency-based therapeutic strategies

German Research Foundation to Stefan Garczyk

 
2019 -
Project list item
Efficacy of immunotherapy in the first and second line treatment of metastatic bladder cancer

German Research Foundation to Philipp Dahm, Philipp Maisch

 
2019 -
Project list item
BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, nonâ muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial.

National Health and Medical Research Council to Dickon Hayne

USD 1,103,245
2019 -
Project list item
Specific Inhibition of NOTCH2 Signaling in Bladder Cancer

German Research Foundation to Peter Black, Gerald Bastian Schulz

 
2019 - 2020
Project list item
The role of a new molecular driver in bladder cancer

National Cancer Institute to DALEY MORERA

USD 90,032
2018 - 2021
Project list item
A co-clinical trial of chemotherapy response in bladder cancer using patient-derived tumor organoids

V Foundation for Cancer Research to Michael M Shen

USD 600,000
2018 - 2021
Project list item
Modulation of regulatory T cells in the bladder tumor environment by anti-PD-L1 immunotherapy

Bladder Cancer Advocacy Network to David Yoonsuk Oh, Lawrence Fong

USD 50,000
2018 - 2019
Project list item
Effects of OncoTherad immunotherapy (MRB-CFI-1) on tumor progression and survival of animals with non-muscle invasive bladder cancer (NMIBC): determination of potential mechanisms of action

São Paulo Research Foundation to Wagner José Fávaro

 
2018 - 2019
Project list item
New therapeutic approaches for non-muscle invasive bladder cancer (NMIBC): intravesical use of OncoTherad biological response modifier and its association with platelet rich plasma (PRP)

São Paulo Research Foundation to Wagner José Fávaro

 
2018 - 2020
Project list item
Identifying DNA Biomarkers of Bacillus Calmette-Guerin (BCG) Resistance in Non-Muscle-Invasive Bladder Cancer

Canadian Institutes of Health Research to Jack Victor Warren Bacon, Alexander William Wyatt

USD 847
2018 - 2019
Project list item
Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma.

European Commission

USD 4,840,188
2018 - 2022
Project list item
Urinary microbiota characterization of superficial bladder Cancer patients undergoing BCG immunotherapy

São Paulo Research Foundation to Anamaria Aranha Camargo

 
2018 - 2022
Project list item
Further Development of Multi-Antigen Vaccines for Primary and Secondary Prevention of Bladder Cancer HHSN2612015000361 TO: HHSN26100011 PP: 9/17/2018 to 3/16/2020

National Cancer Institute to CLINTON GRUBBS

USD 670,206
2018 - 2020
Project list item
Further Development of Multi-Antigen Vaccines for Primary and Secondary Prevention of Bladder Cancer

National Cancer Institute to CLINTON GRUBBS

USD 231,523
2018 - 2020
Project list item
Modeling bladder cancer pathogenesis and tumor evolution

National Cancer Institute to CORY ABATE-SHEN, MICHAEL M. SHEN, DAVID B SOLIT, HIKMAT AL-AHMADIE

USD 3,432,927
2018 - 2023
Project list item
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer

National Cancer Institute to RANDY F. SWEIS

USD 425,338
2018 - 2022
load more...